Recent research has shown that DOT1L changes the genomic accessibility of NF-kB, regulates the expression of the downstream inflammatory factors CCL5 and CXCL10 of the NF-kB pathway, and prevents the occurrence of atherosclerosis in mice [21]. Here, NFKB1 is linked to atherosclerosis.